NASDAQ:FNCH

Finch Therapeutics Group (FNCH) Stock Price, News & Analysis

$1.94
+0.02 (+1.04%)
(As of 05/17/2024 08:53 PM ET)
Today's Range
$1.92
$2.04
50-Day Range
$1.88
$3.42
52-Week Range
$1.86
$16.74
Volume
9,200 shs
Average Volume
38,307 shs
Market Capitalization
$3.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FNCH stock logo

About Finch Therapeutics Group Stock (NASDAQ:FNCH)

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524, FIN-525, and other microbiome product candidates for inflammatory bowel disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.

FNCH Stock Price History

FNCH Stock News Headlines

Finch Therapeutics Group (NASDAQ: FNCH)
Finch Therapeutics Group Inc (FNCH)
Finch Therapeutics Group Inc FNCH
8-K: Finch Therapeutics Group, Inc.
FINCH THERAPEUTICS GROUP INC
Finch Therapeutics Group (FNCH) Gets a Buy from H.C. Wainwright
See More Headlines
Receive FNCH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/25/2024
Today
5/19/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:FNCH
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$-74,750,000.00
Pretax Margin
-73,098.12%

Debt

Sales & Book Value

Annual Sales
$110,000.00
Book Value
$11.86 per share

Miscellaneous

Free Float
885,000
Market Cap
$3.12 million
Optionable
No Data
Beta
0.46
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

FNCH Stock Analysis - Frequently Asked Questions

How have FNCH shares performed in 2024?

Finch Therapeutics Group's stock was trading at $3.61 at the start of the year. Since then, FNCH stock has decreased by 46.3% and is now trading at $1.94.
View the best growth stocks for 2024 here
.

When is Finch Therapeutics Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024.
View our FNCH earnings forecast
.

How were Finch Therapeutics Group's earnings last quarter?

Finch Therapeutics Group, Inc. (NASDAQ:FNCH) issued its quarterly earnings data on Monday, March, 25th. The company reported ($1.89) earnings per share for the quarter.

When did Finch Therapeutics Group's stock split?

Finch Therapeutics Group's stock reverse split on the morning of Monday, June 12th 2023. The 1-30 reverse split was announced on Monday, June 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Finch Therapeutics Group IPO?

Finch Therapeutics Group (FNCH) raised $101 million in an initial public offering (IPO) on Friday, March 19th 2021. The company issued 6,300,000 shares at $15.00-$17.00 per share. BofA Securities, Jefferies and Evercore ISI served as the underwriters for the IPO.

Who are Finch Therapeutics Group's major shareholders?

Finch Therapeutics Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Lake Street Advisors Group LLC (1.32%). Insiders that own company stock include Jeffery A Smisek, Jeffery A Smisek, Marc Blaustein and Nicholas Haft.
View institutional ownership trends
.

How do I buy shares of Finch Therapeutics Group?

Shares of FNCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FNCH) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners